CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing research & development activities in the biopharmaceutical industry
3.4.1.2. Technological advancements in protein engineering
3.4.1.3. Increase in developmental strategies in protein engineering by key players
3.4.2. Restraints
3.4.2.1. High cost and maintenance of protein engineering systems
3.4.3. Opportunities
3.4.3.1. Growth in opportunities in emerging markets
CHAPTER 4: PROTEIN ENGINEERING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Software
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Rational or Site Directed Mutagenesis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Irrational or Random Mutagenesis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Monoclonal Antibodies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Insulin
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Erythropoietin
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Interferon
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Others
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
CHAPTER 7: PROTEIN ENGINEERING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Academic Research Institutes
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Contract Research Organizations
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PROTEIN ENGINEERING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Technology Type
8.2.4. Market size and forecast, by Protein Type
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product
8.2.6.1.2. Market size and forecast, by Technology Type
8.2.6.1.3. Market size and forecast, by Protein Type
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product
8.2.6.2.2. Market size and forecast, by Technology Type
8.2.6.2.3. Market size and forecast, by Protein Type
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product
8.2.6.3.2. Market size and forecast, by Technology Type
8.2.6.3.3. Market size and forecast, by Protein Type
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Technology Type
8.3.4. Market size and forecast, by Protein Type
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product
8.3.6.1.2. Market size and forecast, by Technology Type
8.3.6.1.3. Market size and forecast, by Protein Type
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product
8.3.6.2.2. Market size and forecast, by Technology Type
8.3.6.2.3. Market size and forecast, by Protein Type
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product
8.3.6.3.2. Market size and forecast, by Technology Type
8.3.6.3.3. Market size and forecast, by Protein Type
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product
8.3.6.4.2. Market size and forecast, by Technology Type
8.3.6.4.3. Market size and forecast, by Protein Type
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product
8.3.6.5.2. Market size and forecast, by Technology Type
8.3.6.5.3. Market size and forecast, by Protein Type
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product
8.3.6.6.2. Market size and forecast, by Technology Type
8.3.6.6.3. Market size and forecast, by Protein Type
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Technology Type
8.4.4. Market size and forecast, by Protein Type
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product
8.4.6.1.2. Market size and forecast, by Technology Type
8.4.6.1.3. Market size and forecast, by Protein Type
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product
8.4.6.2.2. Market size and forecast, by Technology Type
8.4.6.2.3. Market size and forecast, by Protein Type
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product
8.4.6.3.2. Market size and forecast, by Technology Type
8.4.6.3.3. Market size and forecast, by Protein Type
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product
8.4.6.4.2. Market size and forecast, by Technology Type
8.4.6.4.3. Market size and forecast, by Protein Type
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product
8.4.6.5.2. Market size and forecast, by Technology Type
8.4.6.5.3. Market size and forecast, by Protein Type
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product
8.4.6.6.2. Market size and forecast, by Technology Type
8.4.6.6.3. Market size and forecast, by Protein Type
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Technology Type
8.5.4. Market size and forecast, by Protein Type
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product
8.5.6.1.2. Market size and forecast, by Technology Type
8.5.6.1.3. Market size and forecast, by Protein Type
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product
8.5.6.2.2. Market size and forecast, by Technology Type
8.5.6.2.3. Market size and forecast, by Protein Type
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product
8.5.6.3.2. Market size and forecast, by Technology Type
8.5.6.3.3. Market size and forecast, by Protein Type
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product
8.5.6.4.2. Market size and forecast, by Technology Type
8.5.6.4.3. Market size and forecast, by Protein Type
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Thermo Fisher Scientific Inc.
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Promega Corporation
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.4. New England Biolabs, Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.5. Danaher Corporation
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Creative Biolabs Limited
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.7. Bio-Rad Laboratories, Inc.
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Amgen, Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Jena Bioscience GmbH
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. TAKARA HOLDINGS INC.
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
| ※参考情報 タンパク質工学は、生物学における重要な分野であり、特定の機能や特性を持つタンパク質を設計、改良、合成する技術を指します。この分野は、分子生物学、遺伝子工学、構造生物学、計算生物学などの知識を統合し、さまざまな生物学的および産業的ニーズに応えることを目的としています。 タンパク質工学にはいくつかの種類があります。まず一つは「フォワードエンジニアリング」で、これは天然のタンパク質の機能を向上させるために構造を設計し、選択的に変更を加える方法です。次に「バックワードエンジニアリング」があり、これは既存のタンパク質の構造を解析し、その構造に基づいて新たなタンパク質を設計するアプローチです。 また、タンパク質工学には特定の目的に応じた多様な技術が利用されます。「サイトダイレクトミュータージェネシス」という手法は、特定のアミノ酸を標的にして置換する方法であり、これにより機能や安定性を改善することが可能です。また「ハイスループットスクリーニング」技術も重要で、数千から数百万のタンパク質変異体を迅速に評価することができ、効率的に目的の機能を持つタンパク質を選定することができます。 タンパク質工学の用途は多岐にわたります。医療分野では、特定の病気に対する治療薬や診断薬の開発が進められています。例えば、モノクローナル抗体や酵素療法は、がんや自己免疫疾患の治療に利用されています。さらに、ワクチンの開発にもタンパク質工学が活用されており、抗原を改良することで免疫応答を強化することができます。 工業用途としては、酵素の改良や新規酵素の開発が挙げられます。これにより、製造過程の効率化やコスト削減が実現されます。例えば、バイオ燃料の生産や食品加工、洗剤の成分として酵素が利用されています。また、環境問題への対応として、特定の廃棄物を分解する酵素が開発されることもあります。 最近の技術進歩により、タンパク質工学は急速に発展しています。次世代シーケンシング技術の発展により、遺伝子の特定や機能解析が容易になりました。また、CRISPR技術を用いた遺伝子編集により、特定の遺伝子に対する変更が簡単に行えるようになったことも、この分野の進展に寄与しています。 さらに、計算生物学の進歩により、タンパク質の構造予測や相互作用解析が行いやすくなり、設計の精度が向上しています。これにより、タンパク質の機能を予測し、設計する能力が飛躍的に向上しました。 今後の展望としては、個別化医療分野での応用が期待されます。患者の遺伝情報に基づいた特定のタンパク質を用いた治療法が開発されることで、より効果的な治療法が提供される可能性があります。また、持続可能な社会に向けたバイオテクノロジーの進展も、タンパク質工学の発展により支えられています。 このように、タンパク質工学は現代のバイオテクノロジーにおいて中心的な役割を果たしており、今後も多くの分野での応用が期待されます。各種技術の進化が新たな発見や革新的な解決策を生むことにより、科学の進展に大きく寄与することでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
